Bobzin, S., Yang, S., Kasten, T. 2000. Application of liquid chromatography-nuclear magnetic resonance spectroscopy to the identification of natural products. J Chromatogr B Biomed Sci Appl. 748:259-267.

Davidson, S. and Haygood, M. 1999. Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula". Biological Bulletin. 196:273-280.

De Clercq, E. 2000. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Medical Research Review. 20:323-349.

Faulkner, J. 1993. Academic chemistry and the discovery of bioactive marine natural products. In: Attaway, D. and Zaborsky, O. (editors). Marine Biotechnology, Volume 1: Pharmaceutical and Bioactive Natural Products. New York: Plenum Press. pp. 459-473.

Faulkner, J. 1995. Chemical riches from the oceans. Chemistry in Britain. 31:680-684.

Faulkner, J. 2000. Highlights of marine natural products chemistry (1972-1999). Natural Products Reports. 17:1-6.

Faulkner, J. 2000. Marine Chemistry. Antonie van Leeuwnhoek. 77:135-145.

Faulkner, J., Harper, M., Haygood, M., Salomon, C., Schmidt, E. 2000. Symbiotic bacteria in sponges: Sources of bioactive substances. In: Fusetani, N. (editor). 2000. Drugs from the Sea. Basel: Karger editions. pp. 107-119.

Fenical, W. 1996. Marine biodiversity and the medicine cabinet: The status of new drugs from marine organisms. Oceanography. 9:23-27.

Folkman, J. 1996. Fighting cancer by attacking its blood supply. Scientific American. 275:150-154.

Haygood, M. and Davidson, S. 1997. Small-subunit rRNA genes and in situ hybridization with oligonucleotides specific for the bacterial symbionts in the larvae of the bryozoan Bugula neritina and proposal of "Candidatus Endobugula sertula". Applied and Environmental Microbiology. 63:4612-4616.

Henkel, J. 1998. Drugs of the Deep: Treasures of the sea yield some medical answers and hint at others. (URL: http://www.fda.gov/fdac/features/1998/198_deep.htm)

Lang, C. 1994. A comparison of terrestrial and marine chemical ecology. (URL: http://www.colostate.edu/Depts/Entomology/courses/en570/papers_1994/lang.html)

Le Corfec, J.M. 1998. Plancton, le seul vrai trésor des océans. Le Figaro Magazine. (Nov. 1998):34-42.

Lee, A. and Langer, R. 1983. Shark cartilage contains inhibitors of tumour angiogenesis. Science. 221:1185-1187.

Luer, C. 1986. Inhibitors of angiogenesis from shark cartilage. Federal Proceedings. 45:949.

Mayer, A. and Lehmann, V. 2000. Marine Pharmacology in 1998. The Pharmacologist. 42:62-69.

Nuijen, B., Bouma, M., Manada, C., Jimeno, J., Schellens, J., Bult, A., Beijnen, J. 2000. Pharmaceutical development of anticancer agents derived from marine sources. Anticancer drugs. 11:793-811.

Qureshi, A., Colin, P., Faulkner, J. 2000. Microsclerodermins F-I, Antitumor and Antifungal Cyclic Peptides from the Lithistid Sponge Microscleroderma sp. Tetrahedron. 56:3679-3685.

Ruoslahti, E. 1996. How cancer spreads. Scientific American. 275:72-77.

Tardieu, V. 2001. Les médicaments de la mer. Science & Vie. 1002:86-95.

Sheu, J., Fu, C., Tsai, M., Chung, W. 1998. Effects of U-995, a potent shark cartilage-derived angiogenesis inhibitor on anti-angiogenesis and anti-tumor activities. Anticancer Research. 18:4435-4441.

Scheuer, P. 1990. Some marine ecological phenomena: chemical basis and biomedical potential. Science. 248:173-177.

UCSD SIO scientists. 2000. Marine Biotechnology and Biomedicine. (URL: http://www.sio.ucsd.edu/about_scripps/research_overview/cmbb.html)

UCSD SIO scientists. 2001. New Marine Products Research & Development. (URL: http://www-csgc.ucsd.edu/communication/research/MP.html)

Wall, N., Mohammad, R., Reddy, K., Al-Katib, A. 2000. Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh. International Journal of Molecular Medicine. 5:165-171.

http://www.sio.ucsd.edu/about_scripps/research_overview/cmbb.html

http://www-csgc.ucsd.edu/communication/research/MP.html

http://www.aims.gov.au/pages/marine-bioproducts/mb-sp03.html

http://www.ag.auburn.edu/biotech/seagrant.htm

http://www.mrd.ucsd.edu/jf/

http://www.fda.gov/fdac/features/1998/198_deep.htm